Canadian COVID-19 vaccine manufacturer Medicago Inc. shutting down
After 24 years in operation, a Quebec-based drug manufacturer that produced a Canadian COVID-19 vaccine and other plant-based drugs is closing.
Parent company Mitsubishi Chemical Group announced on Thursday it plans to shut down Medicago Inc., headquartered in Quebec City, "in due course, in accordance with local laws and regulations."
Medicago, which began operating in Quebec in 1999, describes itself as "one of few" manufacturers in the world with the capability to develop both vaccines and monoclonal antibody treatments, which are used to prevent and treat a broad range of diseases, including cancers, Crohn's disease, arthritis, multiple sclerosis and COVID-19.
Last year, Health Canada approved Medicago's plant-based COVID-19 vaccine, Covifenz, for adults aged 18 to 64. The vaccine was meant to be administered in two doses, and clinical trials showed it was 71 per cent effective in preventing COVID-19 infection beginning one week after the second dose.
In October 2020, before the vaccine was approved, the federal government penned a deal to buy up to 76 million doses of the drug, in addition to providing $173 million in funding to support the vaccine's development and the construction of a new Quebec City manufacturing plant.
Medicago had been preparing to launch commercial-scale production of the vaccine, but its parent company announced Friday it would cease all of its operations, citing changes to the COVID-19 vaccine landscape, global demand for COVID-19 vaccines ,and "Medicago’s challenges in transitioning to commercial-scale production."
"The group judged that it was not viable to continue to make further investment in the commercialization of Medicago’s development products, and decided to cease all of its operations at Medicago and proceed with an orderly wind up of its business and operations," according to a statement published on Mitsubishi Chemical Group's website Thursday.
In a post to Twitter on Thursday, Quebec City Mayor Bruno Marchand called the closure a "huge pity."
"My thoughts are with the families who learned some very sad news today," he wrote in French. "We have to roll up our sleeves to keep all this expertise in the field of health innovation in Quebec."
With files from The Canadian Press
COVID-19 COVERAGE
CTVNews.ca Top Stories
DEVELOPING | Budget 2023 prioritizes pocketbook help and clean economy, deficit projected at $40.1B
In the 2023 federal budget, the government is unveiling continued deficit spending targeted at Canadians' pocketbooks, public health care and the clean economy.

BREAKING | Budget 2023 proposes across-the-board 3 per cent spending cut for government departments
The federal budget proposes an across-the-board three per cent spending cut for all departments and agencies, a belt-tightening move after years of massive growth in the federal public service.
Feds outline $83B in clean economy tax credits in bid to compete with U.S. incentives
Serious money is heading for Canadian industries looking to reduce emissions after the federal government unveiled its answer to the U.S. Inflation Reduction Act.
Could Canada soon standardize USB chargers? Feds looking into it, budget says
Tucked into the 2023 federal budget unveiled on Tuesday in Ottawa, the Liberals have announced plans to explore implementing a standard charging port across Canada, in an effort to save Canadians some money and reduce waste.
Young children, the head of their school and its custodian. These are the victims of the Nashville school shooting
Another American community is reeling after a shooter killed three 9-year-olds and three adults at a private Christian elementary school in Nashville. These are the three children and three adults whose lives were taken by the shooter.
Nashville police release chilling security camera footage of suspected school shooter
Nashville police have released security camera footage of a suspected shooter entering the private Christian elementary school. The shooting claimed the lives of three children, all aged nine, and three adults.
Who was uphill? Gwyneth Paltrow trial spotlights skier code
Gwyneth Paltrow's highly publicized ski collision trial is shining a spotlight on the unspoken rules that govern behaviour on the slopes. Testimony over the last six days has repeatedly touched on skier's etiquette -- especially sharing contact information after a collision, and ski turn radiuses -- in what experts have said is the most high-profile ski collision trial in recent history.
Federal government capping excise tax on alcohol after outcry
The increase in excise duties on all alcoholic products is being temporarily capped at two per cent starting next month instead of a planned six per cent increase.
Nearly all Canadian adults had COVID antibodies for about half of 2022, most through previous infection: survey
A newly released survey finds nearly all Canadian adults had antibodies against COVID-19 for about half of 2022, with most acquiring them through a previous infection.